[ad_1]
Even in optimistic scenarios, vaccination against the SARS-CoV-2 virus can only be applied early next year at the earliest.
According to an optimistic scenario, the new coronavirus vaccine could be authorized in about a year, the European Union Medicines Agency (EMA) said Thursday, according to the MTI.
Marco Cavaleri, head of EMA’s vaccine department, said they are in contact with 33 developers and are doing everything possible to speed up the vaccine approval process. But there are things they do not do: they do not abandon the third phase of the test, when more people are vaccinated, the amount injected is evaluated and the monitoring of the vaccinated people also begins.
“Since the development of a new vaccine has to start from scratch, the optimistic scenario is one year, so the vaccine could not be available until early 2021 at the latest,” said an EMA spokesman who would not expect that vaccinations start in September or fall. use. He ruled out the possibility of exceptionally skipping the third phase of vaccine trials, which he said was absolutely necessary to ensure that the new vaccine was safe and truly effective.
In addition to vaccine development, EMA is investigating 115 different therapies to treat coronavirus disease. According to Cavaleri, some new treatments could be authorized in Europe as early as summer, but he did not provide specific details. Other researchers also warn that precipitation can be dangerous.
[ad_2]
